These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22438)

  • 41. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 42. [Acute toxicity of glafenine (Glifanan)].
    Estenne M; Naeije R; Ketelbant-Balasse P; Gausset P; Demanet JC
    Acta Clin Belg; 1979; 34(4):208-13. PubMed ID: 43061
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of oral anticoagulant (marcumar) on prothrombin and related components in blood coagulation.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    Circ Res; 1957 May; 5(3):252-6. PubMed ID: 13427137
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential effect of the enantiomers of phenprocoumon and warfarin on the vitamin K1-epoxide/vitamin K1 ratio in rat plasma.
    Schmidt W; Beermann D; Oesch F; Jähnchen E
    J Pharm Pharmacol; 1979 Jul; 31(7):490-1. PubMed ID: 38329
    [No Abstract]   [Full Text] [Related]  

  • 45. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics.
    Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
    Eur J Clin Pharmacol; 1999 Jan; 54(11):857-64. PubMed ID: 10027661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
    Mönig H; Baese C; Heidemann HT; Ohnhaus EE; Schulte HM
    Br J Clin Pharmacol; 1990 Jul; 30(1):115-8. PubMed ID: 2390422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of lepirudin, argatroban and melagatran and additional influence of phenprocoumon on ecarin clotting time.
    Fenyvesi T; Jörg I; Weiss C; Harenberg J
    Thromb Res; 2003; 111(1-2):89-94. PubMed ID: 14644085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Hydroxycoumarin oral anticoagulants: pharmacokinetics-response relationship.
    Thijssen HH; Hamulyák K; Willigers H
    Thromb Haemost; 1988 Aug; 60(1):35-8. PubMed ID: 3187945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tooth extraction in Marcumar-treated patients].
    Ackermann K
    ZFA (Stuttgart); 1976 Sep; 52(25):1293. PubMed ID: 790804
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
    Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
    J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D; Beermann D; Oesch F; Jähnchen E
    J Pharm Pharmacol; 1980 Dec; 32(12):828-32. PubMed ID: 6110746
    [No Abstract]   [Full Text] [Related]  

  • 55. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD; Zurborn KH
    Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anticoagulation with phenprocoumon in early childhood: dosage, complications, effectiveness].
    Engelhardt W; Mühler E; von Bernuth G
    Klin Padiatr; 1989; 201(1):21-7. PubMed ID: 2495384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of anticoagulants on blood viscosity].
    Schäbitz J; Petri A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):301-8. PubMed ID: 6194063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin use decreases coagulation in users of vitamin K antagonists.
    van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.